Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 24:10:2050313X221106987.
doi: 10.1177/2050313X221106987. eCollection 2022.

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report

Maroun Bou Zerdan  1 , Ramzi Hamouche  2 , Youssef Bouferraa  3 , Camil Chouairy  4 , Dany Gholam  5
Affiliations
Case Reports

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report

Maroun Bou Zerdan et al. SAGE Open Med Case Rep. .

Abstract

Malignancies with unknown primaries contribute to a small yet significant percentage of overall tumors. Neuroendocrine carcinomas, a rare disease with a poor prognosis, have been known to present as an unknown primary. Treatment consists of cytotoxic chemotherapy but given the latter's high toxicity profile new treatment options are being explored. In this case report, we describe a case of a patient with poorly differentiated neuroendocrine carcinoma of unknown primary treated with compassionate oral everolimus after his refusal of intravenous chemotherapy.

Keywords: Everolimus; hematology; oncology; poorly differentiated neuroendocrine carcinoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Coronal scans of the adrenals (1), inguinal region (2), pelvic area (3), portocaval (4), axillary (5), hilar (6), and peri-psoas muscle areas (7). Sagittal scan of the cervical area (8).
Figure 2.
Figure 2.
I(a): CD56 ×100; Positive membranous staining. I(b): CK7 ×400; Positive cytoplasmic staining of tumor cells with characteristic perinuclear dots. I(c): TTF1 ×100; Positive nuclear staining. I(d): Synaptophysin ×100; Positive cytoplasmic staining. II(a): HE ×100; The tumor cells are arranged in nests of variable size and shape, some of which exhibiting peripheral nuclear palisading, set within a desmoplastic stroma. II(b): HE ×400; Mitotic figures are also easily detected. II(c): HE ×400; Tumor cells have high nuclear to cytoplasmic ratio and exhibit an oval to round nucleus with finely granular chromatin. Occasional necrotic areas are present (left upper area). II(c): HE ×40; Sheets of metastatic small cell carcinoma cells (left lower half) in a lymph node (residual lymphocytes at the periphery).
Figure 3.
Figure 3.
Ki-67 immunohistochemical stain revealing expression by approximately 80% of the neoplastic cells. Original magnification 200×.
Figure 4.
Figure 4.
Initial (left) FDG-PET showing increased uptake in several organs versus mild progress seen in a comparable image 6 months later (right).
See this image and copyright information in PMC

References

    1. Greco FA, Hainsworth JD. Cancer of unknown primary site. Oncology 2006; 379: 1119–1132.
    1. Spigel DR, Hainsworth JD, Greco FA, et al.. Neuroendocrine carcinoma of unknown primary site. Semin Oncol 2009; 36: 52–59. - PubMed
    1. Moertel CG, Lefkopoulo M, Lipsitz S, et al.. Streptozocin–doxorubicin, streptozocin–fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992; 326(8): 519–523. - PubMed
    1. Mitry E, Baudin E, Ducreux M, et al.. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81(8): 1351–1355. - PMC - PubMed
    1. Basturk O, Yang Z, Tang LH, et al.. The high grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogeneous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 2015; 39(5): 683–690. - PMC - PubMed

Publication types

LinkOut - more resources